MaxCyte, Inc. (AIM:MXCT)

MaxCyte Revenue

MaxCyte had revenue of $10.39M USD in the quarter ending March 31, 2025, a decrease of -8.39%. This brings the company's revenue in the last twelve months to $37.68M, down -14.48% year-over-year. In the year 2024, MaxCyte had annual revenue of $38.63M, down -6.44%.

• Revenue (ttm): $37.68M
• Revenue Growth: -14.48%
• P/S Ratio: 6.02
• Revenue / Employee: $330.48K
• Employees: 114
• Market Cap: 175.59M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	38.63M	-2.66M	-6.44%
Dec 31, 2023	41.29M	-2.97M	-6.72%
Dec 31, 2022	44.26M	10.37M	30.59%
Dec 31, 2021	33.89M	7.73M	29.52%
Dec 31, 2020	26.17M	4.55M	21.04%